Genenta is a clinical stage immuno oncology-company
Joined September 2014
- Tweets 43
- Following 12
- Followers 275
- Likes 66
23 Photos and videos
8 Jul 2023
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET @pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake @SergioAbrignani @niaforg @NucleateHQ @issnaf @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
1
1
4
544
Genenta Science (NASDAQ:GNTA) retweeted
30 Jun 2023
1
3
291
Genenta Science (NASDAQ:GNTA) retweeted
3 Jul 2023
@GenentaScience @Nasdaq $GNTA on #INNLIFES by #MichelaMoretti
@NaldiniLab @AssobiotecNews @SIMEST_IT @clusteralisei @Cluster_LLS
innlifes.com/biotech/paracch…
1
2
4
290
3 Jul 2023
Join us Innovit for Life Sciences July 11 8.30amPDT/5.30pmCET
@pigiparacchi @GenentaScience (@Nasdaq:GNTA) @MiraChaurushiya @BioWestlake
@SergioAbrignani
@niaforg @NucleateHQ @issnaf @assoiotecnews @innovitsf @AssobiotecNews @Farmindustria bit.ly/3JBgL0Z
2
2
4
706
Genenta Science (NASDAQ:GNTA) retweeted
21 Jun 2023
"Strategico avere sperimentazioni cliniche e pre-cliniche in Italia per impatto rilevante sulla vita di tutti noi. Alla base dello sviluppo di una nuova #terapia ci sono le #imprese, grandi ma anche medio-piccole". Il nostro consigliere @pigiparacchi live: bit.ly/42VmfKS
2
3
270
Genenta Science (NASDAQ:GNTA) retweeted
21 Jun 2023
Nucleate welcomes this conversation on connecting international biotech investors and founders in Italy.
We thank our Nucleate Italy and @pigiparacchi for organizing.
x.com/GenentaScience/status/…
20 Jun 2023
2
5
1,215
Genenta Science (NASDAQ:GNTA) retweeted
19 Jun 2023
Da un'idea alla quotazione in borsa: quella di @GenentaScience è la storia di un vero caso di successo. Al #SIOS23 Summer ci sarà @pigiparacchi, CEO e co-founder di Genenta Science (Nasdaq: $GNTA)
Registrati👉 bit.ly/43c3FPk
Main partner @SACEgroup in collab. @UniLUISS
1
6
7
548
Genenta Science (NASDAQ:GNTA) retweeted
20 Jun 2023
@GenentaScience $GNTA at #SIOS23 @startup_italia in Rome on 27th @UniLUISS @ProfPrencipe @SACEgroup
@INNOVUPnet @AssobiotecNews @SIMEST_IT @Assolombarda @NaldiniLab @clusteralisei @Cluster_LLS $XBI #biotech
2
6
293
Genenta Science (NASDAQ:GNTA) retweeted
20 Jun 2023
@GenentaScience $GNTA tomorrow with @AssobiotecNews #OneHealth @OdcecMilano
odcec.mi.it/eventi/2023/06/2…
1
4
73
20 Jun 2023
Join the the first fireside chat #InnovitforLifeSciences that brings together the competitiveness of 🇮🇹 Life Sciences 🩺and the experience of 🇺🇸 Investors 🎆
Registration: bit.ly/27June23
@GenentaScience @NIH
1
2
4
2,051
20 Jun 2023
Join us for a live session that brings together the competitiveness of Italian Life Sciences and the experience of US Investors.
Innovit for Life Sciences > Road to #JPM24
On Tuesday 27th June 2023 10.30am EDT - 4.30pm CET
@GenentaScience @AssobiotecF
1
1
5
211
9 May 2023
Join us June 22, 7.30pm live at POLIMI – Graduate School of Management with @pigiparacchi CEO @GenentaScience
eventbrite.com/e/biglietti-p…
1
2
136
9 May 2023
@GenentaScience is at Sidoti Virtual Event May 10 2023 with our @pigiparacchi CEO and Co-founder , join us
8 May 2023
See these #healthcare management teams present live and submit your questions during their Q&A. $ACU $CYTO $ANPC $BXRX $CRDL $COYA $HUGE $GNTA $GNPX $HILS $HUMA $INFU $IKT $KTRA
ow.ly/fqFJ30svfWR
All investors are welcome to join free of charge:
ow.ly/KCPS30svfWS
1
1
151
5 May 2023
True or False: Cell therapy refers to the transfer of autologous or allogeneic cellular material into a patient for medical purposes
100%
True
0%
False
4 votes • Final results
1
2
91
4 May 2023
Our lead candidate is a lenti-virus based hematopoietic stem progenitor cell #immunotherapy enabling controlled and targeted interferon-α expression within #cancers. Learn more: bit.ly/3VGjoT3
3
2
180
27 Apr 2023
At Genenta, our scientists bring a unique blend of multi-disciplinary competence, vast experience in #CellTherapy, and a commensurate track-record in the forefront of therapies and #DrugDevelopment. Learn more: bit.ly/40xHqBL
1
1
141
25 Apr 2023
Meet Richard B. Slansky, Chief Financial Officer at Genenta! Richard is a senior financial executive with more than 30 years of experience at various #biopharmaceutical diagnostic and life science companies. Learn more: bit.ly/3ZV3yGf
1
1
2
315
6 Apr 2023
We're #hiring a new Genenta Science VP Business Development based in New York, New York, United States. Apply today or share this post with your network linkedin.com/feed/update/urn…
2
2
195
28 Mar 2023
Our platform technology triggers the production of alpha-interferon as a therapeutic inside the tumors through a transgene expression control vector, allowing for a robust anti-cancer response with potential minimized systemic toxicity. Check out our MOA: bit.ly/3FXShxs
1
4
172